01 January 2008
Evaluation of the Architect and Dimension tacrolimus and cyclosporine assays
P. Wallemacq, J. S. Gofï¬net, H. Ait-YoucefAnn Transplant 2008; 13(1): 37-38 :: ID: 880197
Abstract
Background: The purpose of this study was to evaluate relative performances of the ARCHITECT and DIMENSION immunoassays, the first requiring preanalytical pretreatment, the last one not.
Material/Methods: Method comparison analyses were performed by testing specimens from transplant recipients. The functional sensitivities (LOQ) of the ARCHITECT and DIMENSION were assessed by testing whole blood specimens spiked with tacrolimus or cyclosporine, run in replicates of 10 on two consecutive days on both instruments. Metabolite cross-reactivity was measured directly in whole blood containing a target concentration of 200 ng/mL cyclosporine and 1,000 ng/mL purified cyclosporine metabolites (AM1, AM1c, AM4N, AM9, AM19). Hematocrit levels were recorded.
Results: The following results were obtained in patient correlation studies: ARCHITECT vs DIMENSION tacrolimus (n=197) Spearman r=0.95, y=0.98x - 0.27 and an average bias of -0.46 ng/mL; ARCHITECT vs DIMENSION cyclosporine (n=95) Spearman r=0.94, y=x - 20 and an average bias of -20.8ng/mL. The LOQ (20%CV) for tacrolimus was 0.6 ng/mL vs 3.1 ng/mL on the ARCHITECT vs DIMENSION, respectively. For cyclosporine these values were 12.1 ng/mL vs 28 ng/mL, respectively for ARCHITECT vs Dimension. Statistical analysis of the 3 ng/mL functional sensitivity panel yielded the following results: ARCHITECT, mean =3.03 ng/mL (95% CI=2.71-3.36); DIMENSION, mean =2.80 ng/mL (95% CI=1.44-4.15). Cyclosporine metabolite cross-reactivity ranged from -0.8% up to 2.2% for the ARCHITECT and from -0.1 up to 6.4% for the DIMENSION, respectively. Hematocrit did not affect any of these assays.
Conclusions: Both assays displayed satisfactory analytical performances. However, from these data, it is suggested that the preanalytical steps involved in the ARCHITECT as says might contribute positively in their analytical performances (particularly the LOQ) as compared to the fully automated DIMENSION.
Keywords: -----, bladder tissue, electrical impedance, first record-able reading, optimal probe pressure, Tacrolimus
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588